Update from Alison Smart / February 2026 скачать в хорошем качестве

Update from Alison Smart / February 2026

Alison Smart, President of the Alliance to Protect Insulin Choice (APIC), joins Nayiri Mississian to share critical updates on the organization's progress in the fight to preserve access to Levemir (insulin detemir). As Novo Nordisk continues to phase out Levemir globally—with supplies expected to be exhausted by December 2026—APIC is leading the charge to ensure patients who rely on this clinically distinct insulin are not left behind. In this update, they discuss: ✅️ Congressional Action: Recent efforts by U.S. leaders urging the HHS and FDA to intervene and protect patient choice. ✅️ Patient Advocacy: Why Levemir’s unique profile is medically necessary for specific groups, including pregnant women, children, and athletes. ✅️ Biosimilar Progress: APIC's work toward securing a manufacturer for awww.alliancetoprotectinsulinchoice.org generic or biosimilar version of detemir to keep it on the market. Visit our website www.alliancetoprotectinsulinchoice.org